This suggests that PPN is a safe DBS target for pediatric secondary dystonia, and that co-stimulation of GPi and PPN may be an effective treatment paradigm for some components of dystonia that are insufficiently treated with GPi stimulation alone. This evidence concerns the gene GPI and Dystonia.